Zobrazeno 1 - 10
of 14
pro vyhledávání: '"UDC 615.276"'
Publikováno v:
Клінічна фармація; Том 24, № 3 (2020); 53-59
Clinical pharmacy; Том 24, № 3 (2020); 53-59
Клиническая фармация; Том 24, № 3 (2020); 53-59
Clinical pharmacy; Vol. 24 No. 3 (2020); 53-59
Клиническая фармация; Том 24 № 3 (2020); 53-59
Клінічна фармація; Том 24 № 3 (2020); 53-59
Clinical pharmacy; Том 24, № 3 (2020); 53-59
Клиническая фармация; Том 24, № 3 (2020); 53-59
Clinical pharmacy; Vol. 24 No. 3 (2020); 53-59
Клиническая фармация; Том 24 № 3 (2020); 53-59
Клінічна фармація; Том 24 № 3 (2020); 53-59
The study of properties of higher fungi, which are a potential source of biologically active substances, is a necessary vector for creating drugs with prophylactic and therapeutic purposes based on fungi and products of their metabolism.Aim. To study
Publikováno v:
Український біофармацевтичний журнал; № 1(62) (2020); 43-49
Ukrainian biopharmaceutical journal; № 1(62) (2020); 43-49
Украинский биофармацевтический журнал; № 1(62) (2020); 43-49
Ukrainian biopharmaceutical journal; № 1(62) (2020); 43-49
Украинский биофармацевтический журнал; № 1(62) (2020); 43-49
Topicality. Over the past decades, traditional medicines, in particular herbal preparations, have become increasingly widespread worldwide, due to their multivector pharmacodynamics, a high enough level of safety and accessibility to a wide populatio
Autor:
Yu. M. Naboka
Publikováno v:
Clinical pharmacy; Том 23, № 4 (2019); 24-29
Клиническая фармация; Том 23, № 4 (2019); 24-29
Клінічна фармація; Том 23, № 4 (2019); 24-29
Клиническая фармация; Том 23, № 4 (2019); 24-29
Клінічна фармація; Том 23, № 4 (2019); 24-29
Згідно з експертною оцінкою ВООЗ 75 % хворих можна вилікувати за допомогою фітозасобів. Тому майбутнє сучасної медицини та фармації пов’
Autor:
Naboka, Yu. M.
Publikováno v:
Clinical pharmacy; Vol. 23 No. 4 (2019); 24-29
Клиническая фармация; Том 23 № 4 (2019); 24-29
Клінічна фармація; Том 23 № 4 (2019); 24-29
Клиническая фармация; Том 23 № 4 (2019); 24-29
Клінічна фармація; Том 23 № 4 (2019); 24-29
According to the WHO expert estimates, 75 % of patients can be cured with the help of herbal remedies. Therefore, the future of modern medicine and pharmacy is associated with the integration of the evidence-based and natural medicine. The drug “Ar
Publikováno v:
Clinical pharmacy; Vol. 21 No. 4 (2017); 42-50
Клиническая фармация; Том 21 № 4 (2017); 42-50
Клінічна фармація; Том 21 № 4 (2017); 42-50
Клиническая фармация; Том 21 № 4 (2017); 42-50
Клінічна фармація; Том 21 № 4 (2017); 42-50
Aim. To study distribution of mometasone furoate (MF) in emulsions of the 1st (o/w) and 2nd (w/o) types with different excipients, as well as to conduct a comparative experimental study of the anti-inflammatory effect of 0.1 % creams of MF with these
Publikováno v:
Clinical pharmacy; Vol. 21 No. 3 (2017); 22-28
Клиническая фармация; Том 21 № 3 (2017); 22-28
Клінічна фармація; Том 21 № 3 (2017); 22-28
Клиническая фармация; Том 21 № 3 (2017); 22-28
Клінічна фармація; Том 21 № 3 (2017); 22-28
Osteoarthritis (OA) is a severe degenerative-dystrophic joint disease. Treatment of OA should be complex with the use of painkillers, anti-inflammatory and chondroprotective agents. The original combined cream-gel with glucosamine hydrochloride, chon
Publikováno v:
Clinical pharmacy; Vol. 20 No. 1 (2016); 12-17
Клиническая фармация; Том 20 № 1 (2016); 12-17
Клінічна фармація; Том 20 № 1 (2016); 12-17
Клиническая фармация; Том 20 № 1 (2016); 12-17
Клінічна фармація; Том 20 № 1 (2016); 12-17
Carboxytherapy based on dosing of carbon dioxide is a popular method for treating many diseases in the world. In medicine carboxytherapy is used to increase the tissue oxygenation that leads to the antiphlogistic and antibacterial activity, as well a
Publikováno v:
Clinical pharmacy; Vol. 20 No. 1 (2016); 39-43
Клиническая фармация; Том 20 № 1 (2016); 39-43
Клінічна фармація; Том 20 № 1 (2016); 39-43
Клиническая фармация; Том 20 № 1 (2016); 39-43
Клінічна фармація; Том 20 № 1 (2016); 39-43
In the model of collagen-induced arthritis in rats studied anti-inflammatory properties of compositions based on a combination of doxycycline hydrochloride and glucosamine hydrochloride in comparative aspect with its active monokomponentamy - doxycyc
Autor:
Shebeko, S. K., Russkin, O. S.
Publikováno v:
Clinical pharmacy; Vol. 20 No. 1 (2016); 49-53
Клиническая фармация; Том 20 № 1 (2016); 49-53
Клінічна фармація; Том 20 № 1 (2016); 49-53
Клиническая фармация; Том 20 № 1 (2016); 49-53
Клінічна фармація; Том 20 № 1 (2016); 49-53
It has been presented the results of the studying on the influence of Diclocor on the functional state indicators of rat’s myocardium in conditions of furazolidone-isadrine lesion. After a medical application of Diclocor the normalization of both,
Publikováno v:
Clinical pharmacy; Vol. 19 No. 4 (2015); 35-39
Клиническая фармация; Том 19 № 4 (2015); 35-39
Клінічна фармація; Том 19 № 4 (2015); 35-39
Клиническая фармация; Том 19 № 4 (2015); 35-39
Клінічна фармація; Том 19 № 4 (2015); 35-39
Nonsteroidal anti-inflammatory drugs (NSAIDs) are among the most widely used groups of medicines. Despite the undeniable clinical effectiveness, their use is associated with the risk of side effects. This fact directs scientific research to searching